Patrick Hayden

Trinity College Dublin School of Medicine

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Collaborators (11)

Jenny Byrne

Assoc prof of Haematology

University of Nottingham

UNITED KINGDOM

Inken Hilgendorf

Universitätsklinikum Jena

Donal P. McLornan

UNITED KINGDOM

Sinisa Savic

Clinical Associate Professor

University of Leeds

UNITED KINGDOM

Ann De Becker

Vrije Universiteit Brussel

Joanna Drozd-Sokołowska

Medical University of Warsaw

Anjum Khan

University of York

UNITED KINGDOM

Thomas Pabst

Grzegorz Helbig

Tomasz Wrobel

Wroclaw Medical University

Angela Hwang

University College London Hospitals NHS Foundation Trust

UNITED KINGDOM

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Patrick Hayden

Research Interests

Explore related searches

Contact this professor

Articles (19)

Collaborators (11)

Jenny Byrne

Inken Hilgendorf

Donal P. McLornan

Sinisa Savic

Ann De Becker

Joanna Drozd-Sokołowska

Anjum Khan

Thomas Pabst

Grzegorz Helbig

Tomasz Wrobel

Angela Hwang

Make your next move.

Patrick Hayden

Research Interests

Explore related searches

Contact this professor

Articles (19)

Sequence not salvage

The role of maintenance therapy following autologous stem cell transplantation in newly diagnosed multiple myeloma: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT

Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT

In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT

Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMT

Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS—a study of the CMWP of the EBMT

Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT

Primary Cancer Matters in Therapy-related Myeloid Neoplasm Patients Receiving Allogeneic Hematopoietic Cell Transplantation: A Study From the Chronic Malignancies Working Party of the EBMT.

Safety and efficacy of autologous stem cell transplantation in dialysis-dependent myeloma patients-The DIADEM study from the chronic malignancies working party of the EBMT.

Early liver complications after allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of the <scp>EBMT</scp>

Allogeneic hematopoietic cell transplant for hairy cell leukemia: EBMT experience.

Upfront autologous transplantation still improving outcomes in patients with multiple myeloma.

Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT.

Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome unclassifiable - a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.

Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the EBMT.

Access to and affordability of CAR T-cell therapy in multiple myeloma: an EBMT position paper.

Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis.

Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT.

Collaborators (11)

Jenny Byrne

Inken Hilgendorf

Donal P. McLornan

Sinisa Savic

Ann De Becker

Joanna Drozd-Sokołowska

Anjum Khan

Thomas Pabst

Grzegorz Helbig

Tomasz Wrobel

Angela Hwang

Make your next move.